WebDec 29, 2024 · Shares of biopharmaceutical concern Ardelyx, Inc. (ARDX) have fallen over 60% since the FDA initially rejected its hyperphosphatemia therapy XPHOZOA in mid-2024. Read more here. WebArdelyx (NASDAQ:ARDX) shareholders have endured a 88% loss from investing in the stock five years ago. Simply Wall St. +5.88%. Jul-01-22 04:01PM. Ardelyx, Inc. Reports Employment Inducement Grants. PR Newswire. Jun-30-22 08:00AM. Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners.
2024-04-13 NDAQ:ARDX Press Release Ardelyx Inc.
WebApr 13, 2024 · WALTHAM, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on April 10, 2024, the compensation committee of the … WebGet the latest Ardelyx Inc (ARDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. purple bit found
3 Penny Stocks to Add to Your Watchlist for Potential Breakouts
WebApr 8, 2024 · ARDX to USD Chart. ARDX to USD rate today is $0.01147743 and has increased 16.6% from $0.009842644132 since yesterday. ArdCoin (ARDX) is on a upward monthly trajectory as it has increased 46.8% from $0.007819029560 since 1 month (30 days) ago. Price. Market Cap. WebStocktwits - The largest community for investors and traders ... /topic/ARDX Web"3.2.2 Safety Summary: Tenapanor is minimally absorbed and, with the exception of diarrhea and tolerability issues resulting in discontinuation of tenapanor and dose reductions, safety analyses did not raise significant concerns." secured web mail